Concerns regarding the use of only phase 2 study to Justify palliative radiotherapy vs. Palliative chemo-radiotherapy in unresectable head and neck cancer

被引：0
|
作者：
Dave, Jay [1 ]
机构：
[1] Shree Doodhadhari Burfani Hosp, ENT HNS, Haridwar, India
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 200卷
关键词：
CHEMOTHERAPY; TRIAL;
D O I：
10.1016/j.radonc.2024.110526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer - A hellenic cooperative oncology group phase III study
    Fountzilas, G
    Ciuleanu, E
    Dafni, U
    Plataniotis, G
    Kalogera-Fountzila, A
    Samantas, E
    Athanassiou, E
    Tzitzikas, J
    Ciuleanu, T
    Nikolaou, A
    Pantelakos, P
    Zaraboukas, T
    Zamboglou, N
    Daniilidis, J
    Ghilezan, N
    MEDICAL ONCOLOGY, 2004, 21 (02) : 95 - 107
  • [42] SAMITAL IN PROPHYLAXIS OF CHEMO-RADIOTHERAPY (CT-RT) INDUCED MUCOSITIS IN HEAD AND NECK SQUAMOCELLULAR CANCER (HNSCC) PATIENTS (PTS): RESULTS OF A PROSPECTIVE MONOINSTITUTIONAL PHASE II TRIAL
    Bossi, P.
    Bergamini, C.
    Mirabile, A.
    Orlandi, E.
    Franceschini, M.
    Olmi, P.
    Granata, R.
    Locati, L. D.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2010, 21 : 328 - 328
  • [43] THE ROLE OF COX-2 INHIBITOR (CELECOXIB) IN COMBINATION WITH CHEMO-RADIOTHERAPY, IN IMPROVEMENT OF THE SURVIVAL AND RESPONSE RATE IN HEAD AND NECK CARCINOMA, PHASE III. RANDOMIZED CLINICAL TRIAL
    Aghili, M.
    Izadi, S.
    Mojahed, M.
    Kazemian, A.
    Farhan, F.
    Samiei, F.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S66 - S66
  • [44] An Institutional Phase I/II Study to Evaluate Safety and Efficacy of High Dose Weekly Hypofractionated Palliative Breast Radiotherapy in Advanced Unresectable or Metastatic Breast Cancer
    Haresh, K. P.
    Arun, T.
    Gupta, S.
    Suhani, S.
    Prashad, R.
    Gupta, P.
    Kumar, D.
    Kumar, S.
    Begum, N.
    Devnani, B.
    Rath, G. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S195 - S195
  • [45] Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
    Barnadas, Agusti
    Mesia, Ricard
    Majem, Margarita
    Galiana, Ramon
    Lopez-Pousa, Antonio
    de Vega, Jose M.
    Margeli, Mireia
    Valenti, Vicente
    Anglada, Lluis
    Lloansi, Ariadna
    Arellano, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04): : 254 - 260
  • [46] Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer definitive results of a phase III study.
    Beltramo, G
    Rampino, M
    Redda, MGR
    Ragona, R
    Orecchia, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S32 - S32
  • [47] Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
    Agustí Barnadas
    Ricard Mesía
    Margarita Majem
    Ramón Galiana
    Antonio López-Pousa
    José M. de Vega
    Mireia Margelí
    Vicente Valentí
    Lluís Anglada
    Ariadna Lloansí
    Antonio Arellano
    Clinical and Translational Oncology, 2011, 13 : 254 - 260
  • [48] The role of imaging (neck ultrasound, magnetic resonance and positron emission tomography-computed tomography) in the management of the neck after chemo-radiotherapy in locally advanced head and neck cancer: Preliminary report of a prospective study.
    Pellini, R.
    Marucci, L.
    Vidiri, A.
    Meduri, GM.
    Di Marzo, A.
    Arcangeli, G.
    Spriano, G.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S41 - S42
  • [49] Radiotherapy with Durvalumab vs. Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer and a Contraindication to Cisplatin: Phase II Results of NRG-HN004
    Mell, L. K.
    Torres-Saavedra, P.
    Wong, S.
    Chang, S.
    Kish, J. A.
    Minn, A. J., III
    Jordan, R.
    Liu, T.
    Truong, M. T.
    Winquist, E.
    Wise-Draper, T.
    Rodriguez, C. P.
    Musaddiq, A.
    Beadle, B. M.
    Henson, C.
    Narayan, S.
    Spencer, S. A.
    Harris, J.
    Yom, S. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (05): : 1058 - 1058
  • [50] Results of a 2 x 2 Phase III Randomized Trial of Synchronous Chemo-radiotherapy (CRT) Compared to Radiotherapy (RT) Alone and Standard vs. Reduced High Volume RT in Muscle Invasive Bladder Cancer (MIBC) (BC2001 CRUK/01/004)
    James, N.
    Hussain, S.
    Hall, E.
    Jenkins, P.
    Tremlett, J.
    Rawlings, C.
    Crundwell, M.
    Waters, R.
    Huddart, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S2 - S3
12345